Rifaximin’s Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility
Condition(s):Cirrhosis, Liver; Minimal Hepatic Encephalopathy; Small Intestinal Bacterial Overgrowth; Gastrointestinal Motility DisorderLast Updated:June 28, 2023Withdrawn